Management of drug-related problems including drug-drug interactions caused by nirmatrelvir/ritonavir in paediatric patients with SARS-CoV-2

被引：2
|
作者：
Yalcin, Nadir [1 ,2 ]
Demirkan, Kutay [1 ]
机构：
[1] Hacettepe Univ, Dept Clin Pharm, Fac Pharm, TR-06100 Ankara, Turkey
[2] Erasmus MC, Dept Clin Pharm, Rotterdam, Netherlands
来源：
ARCHIVES OF DISEASE IN CHILDHOOD | 2023年 / 108卷 / 10期
关键词：
pharmacology; infectious disease medicine; global health;
D O I：
10.1136/archdischild-2022-324168
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions
    Giada Crescioli
    Valentina Brilli
    Cecilia Lanzi
    Andrea Burgalassi
    Alessandra Ieri
    Roberto Bonaiuti
    Elias Romano
    Rinaldo Innocenti
    Guido Mannaioni
    Alfredo Vannacci
    Niccolò Lombardi
    Internal and Emergency Medicine, 2021, 16 : 697 - 710
  • [32] Potential drug-drug interactions in COVID 19 patients in treatment with lopinavir/ritonavir
    Brandariz-Nunez, David
    Correas-Sanahuja, Marcelo
    Guarc, Eva
    Picon, Rafael
    Garcia, Barbara
    Gil, Rocio
    MEDICINA CLINICA, 2020, 155 (07): : 281 - 287
  • [33] Drug Interactions With a Short Course of Nirmatrelvir and Ritonavir: Prescribers and Patients Beware
    Ratain, Mark J.
    Greenblatt, David J.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (08): : 925 - 927
  • [34] Drug-Related Problems in Hospitalised Patients
    Patricia M.L.A. van den Bemt
    Toine C.G. Egberts
    Lolkje T.W. de Jong-van den Berg
    Jacobus R.B.J. Brouwers
    Drug Safety, 2000, 22 : 321 - 333
  • [35] Drug-related problems in hospitalised patients
    van den Bemt, PMLA
    Egberts, TCG
    de Jong-van den Berg, LTW
    Brouwers, JRBJ
    DRUG SAFETY, 2000, 22 (04) : 321 - 333
  • [36] Systematic review of the prevalence and nature of drug-related problems in paediatric patients
    Mi, Xue
    Zeng, Linan
    Zhang, Lingli
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (06) : 776 - 782
  • [37] Drug-related problems in patients with osteoporosis
    Ilic, Darko
    Bukumiric, Zoran
    Jankovic, Slobodan
    VOJNOSANITETSKI PREGLED, 2016, 73 (03) : 261 - 265
  • [38] Drug-drug interactions and dose management of BTK inhibitors when initiating nirmatrelvir/ritonavir (paxlovid) based on physiologically-based pharmacokinetic models
    Li, Chao
    Chen, Lu
    Li, Lixian
    Chen, Wanyi
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 189
  • [39] Drug-drug interaction between paxlovid and tacrolimus in a patient with myasthenia gravis and SARS-CoV-2 infection
    Chen, Ying
    Wan, Wenbin
    Yao, Xiaoying
    Guan, Yangtai
    JOURNAL OF NEUROIMMUNOLOGY, 2023, 385
  • [40] Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions-reply
    Giada Crescioli
    Cecilia Lanzi
    Guido Mannaioni
    Alfredo Vannacci
    Niccolò Lombardi
    Internal and Emergency Medicine, 2021, 16 : 799 - 800
12345